Literature DB >> 12390648

SUNCT syndrome responsive to lamotrigine.

Jose M Gutierrez-Garcia1.   

Abstract

BACKGROUND: Short-lasting, unilateral, neuralgiform headache attacks with conjunctival injection, tearing, rhinorrhea (SUNCT syndrome) is a headache form generally refractory to drug therapy. Occasional patients with SUNCT have been reported with a successful response to lamotrigine.
OBJECTIVE: To report two patients with SUNCT treated with lamotrigine.
METHODS: Clinical history, neurologic examination, and brain magnetic resonance imaging.
RESULTS: Both patients with SUNCT syndrome were successfully treated with lamotrigine. In both cases, when lamotrigine was tapered off, the attacks reappeared, only to disappear when the dose was again increased. In addition, lamotrigine was well tolerated and no undesired side-effects were reported.
CONCLUSION: If the positive effect of lamotrigine in patients with SUNCT is confirmed in other cases, lamotrigine could become the first specific treatment for SUNCT syndrome.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12390648     DOI: 10.1046/j.1526-4610.2002.02187.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  9 in total

Review 1.  Refining the Benefit/Risk Profile of Anti-Epileptic Drugs in Headache Disorders.

Authors:  Michael J Marmura; Aliza S Kumpinsky
Journal:  CNS Drugs       Date:  2018-08       Impact factor: 5.749

2.  SUNCT and SUNA: Recognition and Treatment.

Authors:  Juan A Pareja; Mónica Alvarez; Teresa Montojo
Journal:  Curr Treat Options Neurol       Date:  2013-02       Impact factor: 3.598

Review 3.  Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing syndrome: a review.

Authors:  Manjit S Matharu; Anna S Cohen; Christopher J Boes; Peter J Goadsby
Journal:  Curr Pain Headache Rep       Date:  2003-08

4.  Update on the therapy of the trigeminal autonomic cephalalgias.

Authors:  Marc E Lenaerts
Journal:  Curr Treat Options Neurol       Date:  2008-01       Impact factor: 3.598

Review 5.  Management of trigeminal autonomic cephalgias and hemicrania continua.

Authors:  Manjit S Matharu; Christopher J Boes; Peter J Goadsby
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 6.  Therapeutical approaches to paroxysmal hemicrania, hemicrania continua and short lasting unilateral neuralgiform headache attacks: a critical appraisal.

Authors:  Carlo Baraldi; Lanfranco Pellesi; Simona Guerzoni; Maria Michela Cainazzo; Luigi Alberto Pini
Journal:  J Headache Pain       Date:  2017-07-20       Impact factor: 7.277

7.  Italian guidelines for primary headaches: 2012 revised version.

Authors:  Paola Sarchielli; Franco Granella; Maria Pia Prudenzano; Luigi Alberto Pini; Vincenzo Guidetti; Giorgio Bono; Lorenzo Pinessi; Massimo Alessandri; Fabio Antonaci; Marcello Fanciullacci; Anna Ferrari; Mario Guazzelli; Giuseppe Nappi; Grazia Sances; Giorgio Sandrini; Lidia Savi; Cristina Tassorelli; Giorgio Zanchin
Journal:  J Headache Pain       Date:  2012-05       Impact factor: 7.277

Review 8.  The Neuropharmacology of Cluster Headache and other Trigeminal Autonomic Cephalalgias.

Authors:  Alfredo Costa; Fabio Antonaci; Matteo Cotta Ramusino; Giuseppe Nappi
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

9.  SUNCT syndrome in a child: a rare cause of paroxysmal headache.

Authors:  Aycan Unalp; Aysel Aydogan Oztürk
Journal:  Ann Saudi Med       Date:  2008 Sep-Oct       Impact factor: 1.526

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.